Pharmacological properties of Su-19789B, a unique central nervous system stimulant.
D000315:Adrenalectomy; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects*; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D055598:Chemical Phenomena; D002621:Chemistry; D003510:Cyclohexanes / Q000494:pharmacology* / Q000633:toxicity; D003913:Dextroamphetamine / Q000494:pharmacology; D006591:Hexobarbital / Q000494:pharmacology; D008722:Methods; D008774:Methylphenidate / Q000494:pharmacology; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects*; D009119:Muscle Contraction / Q000187:drug effects; D010880:Piperidines / Q000494:pharmacology* / Q000633:toxicity; D011817:Rabbits; D012018:Reflex / Q000187:drug effects; D012890:Sleep / Q000139:chemically induced
D000928:Antidepressive Agents; D000697:Central Nervous System Stimulants; D003510:Cyclohexanes; D008996:Monoamine Oxidase Inhibitors; D010880:Piperidines; D008774:Methylphenidate; D006591:Hexobarbital; D003913:Dextroamphetamine